Category: Cancer (Page 3)
Get to Know: Hematologist and Medical Oncologist Gwenalyn Garcia, MD
Gwenalyn Garcia, MD, is a fellowship-trained hematologist and medical oncologist who cares for patients at UVA Cancer Center Augusta.
Drug Discovery: A Safer, More Accessible Treatment for Recurrent Pediatric T-ALL
UVA Children's pediatric oncology researchers have developed a molecule to block a key determinant of T-ALL cell survival.
Enhanced Cystoscopy & Innovative Practice Model Minimizes Bladder Cancer Recurrence
Blue light cystoscopy better pinpoints bladder cancer and improves access to life-saving surveillance after diagnosis.
UVA Cancer Center Becomes Only NCI-Designated Comprehensive Cancer Center in Virginia
Through a significant investment over 8 years, we became Virginia's first National Cancer Institute-designated comprehensive cancer center.
An Unhealthy Gut May Contribute to Metastatic Breast Cancer, UVA Health Research Finds
This groundbreaking animal-model research moves us closer to understanding why GI health plays a key role in treating breast cancer.
UVA Researchers Share Key Hematologic Malignancy Insights at National Meeting
Find out why lymphoma and leukemia patients can mount a protective immune response to coronavirus and other findings from UVA Health experts.
How UVA Urology Built a Destination Center for Prostate Cancer Care
With nationally known urologic oncologists and surgeons, UVA prostate cancer patients get top-level care from a ‘SEAL team’ of specialists.
Super Cells: UVA On the Forefront of CAR T-Cell Therapy Treatment and Discoveries
UVA researchers are evaluating a novel CAR T-cell in order to expand this therapy to treat patients with untreatable lymphomas.
Understanding Racial Disparities in Colon Cancer May Lead to More Targeted Prevention and Treatment
Racial disparities in colon cancer rates occur due to how the colon's different sides age. Current research analyzes why.
UVA Research Opening Door to New, Targeted Treatments for Deadliest Brain Tumor
UVA research into treating deadly glioblastomas has found an oncogene to target and a way to use focused ultrasound never before possible.